Antitumor activity of nab-sirolimus versus mTOR inhibitors temsirolimus, sirolimus, and everolimus in A549 NSCLC xenografts. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
A four-condition crossover design (hydromorphone, dronabinol, combination, placebo) in 21 participants showed no additive or ...
Combination of hSTC810 and capecitabine therapy in metastatic colorectal cancer with resistance or intolerance to oxaliplatin and irinotecan-based chemotherapy: A single arm, phase 1b/2, multicenter ...
A new Lancet study says statin side effects are overblown. Headlines are running that millions more people should be taking ...
Combining cannabis with an opioid did not improve acute pain for people with knee arthritis, according to results of a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results